STOCK TITAN

Esperion to Report Fourth Quarter and Full Year 2022 Financial Results February 21, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Esperion (NASDAQ: ESPR) will announce its fourth quarter and full year 2022 financial results on February 21, 2023, before U.S. market open. Following the announcement, management will host a webcast and conference call at 8:00 a.m. ET to discuss the results and upcoming milestones. Investors can pre-register for the call and access a live webcast on the company’s investor section. The replay will be available shortly after the call and archived for 90 days. Esperion focuses on developing innovative cholesterol-lowering therapies, aiming to provide solutions for patients with unmet needs.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report fourth quarter and full year 2022 financial results before the open of the U.S. financial markets on Tuesday, February 21, 2023.

Following the release, company management will host a webcast and conference call at 8:00 a.m. ET to discuss the financial results and upcoming corporate milestones. Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN.

Already registered? Access with your PIN here.

A live webcast can be accessed on the investors and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion Therapeutics
Esperion works hard to make our medicines easy to get, easy to take, and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Esperion Corporate Communications
corporateteam@esperion.com


FAQ

When will Esperion report its financial results for Q4 2022?

Esperion will report its financial results for Q4 2022 on February 21, 2023, before the U.S. market opens.

What time is Esperion's conference call regarding its financial results?

The conference call will take place at 8:00 a.m. ET on February 21, 2023.

How can I access the webcast for Esperion's financial results?

The webcast can be accessed via the investors section of Esperion's website, and a replay will be available for 90 days after the call.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

476.49M
196.07M
0.5%
66.33%
17.05%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR